Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Biogenic Fe3O4 Nanoparticles Synthesized from Rubus ellipticus: Phytochemical Profiling, Structural Characterization, and Multifunctional Biomedical Evaluation.

Created on 13 Jul 2026

Authors

Priyadarshini Chanyal, Vibha Joshi, Mohammad S Javed, Vishwajeet Bachhar, Manisha Duseja, Shashank Shekher Mishra, Shailey Singhal, Naveen Singhal, Nishesh Sharma

Published in

Applied biochemistry and biotechnology. Jul 13, 2026. Epub Jul 13, 2026.

Abstract

The present study reports the green synthesis of iron oxide nanoparticles (Fe3O4 NPs) using the ethanolic leaf extract of Rubus ellipticus (RE), supported by GC-MS profiling. 48 phytochemicals including stigmast-5-en-3-ol, phytol, linoleic acid ethyl ester, neophytadiene, and vitamin E acted as natural reducing and stabilizing agents. The RE-mediated Fe3O4 nanoparticles (RE-Fe) were characterized by using XRD, TEM-EDX, and the XPS analysis. XRD confirmed the highly crystalline, phase-pure magnetite with a cubic spinel structure, and TEM revealed about the quasi-spherical particles averaging 37.73 ± 6.03 nm. XPS validated the mixed Fe²⁺/Fe³⁺ oxidation states typical of the Fe3O4. The Biological evaluation showed the excellent antioxidant activity of the RE-Fe compared to the extract, with an IC50 values of 27.93 and 39.06 µg/mL in DPPH and the phosphomolybdate assays. Antidiabetic assays demonstrated the strong α-amylase and the α-glucosidase inhibition (IC50 = 49.54 and 35.21 µg/mL), outperforming the plant extract. RE-Fe also exhibited the potent antibacterial activity against the bacterial strains E. coli and S. aureus, comparable to ciprofloxacin. Molecular docking supported these outcomes, revealing strong interactions of key phytochemicals with TyrRS, DNA gyrase, α-amylase, and α-glucosidase. Overall, Rubus ellipticus is shown to be an effective source for eco-friendly Fe3O4 NPs synthesis with promising biomedical applications.

PMID:
42437835
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement